Complicaions | ENPG alone group No./Total (%) | Consolidation immunotherapy group No./Total (%) | χ2 | p-value |
---|---|---|---|---|
Nasal congestion | 2 (10.0) | 2 (20.0) | 0.577 | 0.448 |
Dysphagia | 5 (25.0) | 1 (10.0.) | 0.938 | 0.333 |
Nasopharyngeal hemorrhage | 2 (10.0) | 1 (10.0) | 0 | 1.000 |
Nasopharyngeal necrosis | 2 (10.0) | 0 (0) | 1.071 | 0.301 |
Facial numbness | 1 (5.0) | 1 (10.0) | 0.268 | 0.605 |
Limitation of mouth opening | 1 (5.0) | 1 (10.0) | 0.268 | 0.605 |
Cerebral infraction | 1 (5.0) | 0 (0) | 0.517 | 0.472 |